These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
526 related items for PubMed ID: 16775010
1. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA. Zhao BM, Hoffmann FM. Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010 [Abstract] [Full Text] [Related]
2. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. Runyan CE, Schnaper HW, Poncelet AC. J Biol Chem; 2005 Mar 04; 280(9):8300-8. PubMed ID: 15613484 [Abstract] [Full Text] [Related]
3. Expression, purification, and functional characterization of recombinant PTD-SARA. Huang C, Du R, Zhang P, Meng H, Jia H, Song Y, Li M, Zhang Y, Sun S. Acta Biochim Biophys Sin (Shanghai); 2011 Feb 04; 43(2):110-7. PubMed ID: 21266541 [Abstract] [Full Text] [Related]
4. Smad anchor for receptor activation (SARA) in TGF-beta signaling. Tang WB, Ling GH, Sun L, Liu FY. Front Biosci (Elite Ed); 2010 Jun 01; 2(3):857-60. PubMed ID: 20515759 [Abstract] [Full Text] [Related]
5. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. Yang J, Dai C, Liu Y. J Am Soc Nephrol; 2005 Jan 01; 16(1):68-78. PubMed ID: 15537870 [Abstract] [Full Text] [Related]
6. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB. J Am Soc Nephrol; 2005 Mar 01; 16(3):667-75. PubMed ID: 15677311 [Abstract] [Full Text] [Related]
7. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways. Tacheau C, Fontaine J, Loy J, Mauviel A, Verrecchia F. J Cell Physiol; 2008 Dec 01; 217(3):759-68. PubMed ID: 18668519 [Abstract] [Full Text] [Related]
8. aPKC alters the TGFβ response in NSCLC cells through both Smad-dependent and Smad-independent pathways. Gunaratne A, Chan E, El-Chabib TH, Carter D, Di Guglielmo GM. J Cell Sci; 2015 Feb 01; 128(3):487–98. PubMed ID: 25501807 [Abstract] [Full Text] [Related]
9. Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cells. Li R, Wang Y, Liu Y, Chen Q, Fu W, Wang H, Cai H, Peng W, Zhang X. PLoS One; 2013 Feb 01; 8(3):e58848. PubMed ID: 23544048 [Abstract] [Full Text] [Related]
10. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line. He WX, Niu ZY, Zhao SL, Jin WL, Gao J, Smith AJ. Arch Oral Biol; 2004 Nov 01; 49(11):911-8. PubMed ID: 15353247 [Abstract] [Full Text] [Related]
11. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC, de Caestecker MP, Schnaper HW. Kidney Int; 1999 Oct 01; 56(4):1354-65. PubMed ID: 10504488 [Abstract] [Full Text] [Related]
12. SARA and Hgs attenuate susceptibility to TGF-beta1-mediated T cell suppression. Kunzmann S, Wohlfahrt JG, Itoh S, Asao H, Komada M, Akdis CA, Blaser K, Schmidt-Weber CB. FASEB J; 2003 Feb 01; 17(2):194-202. PubMed ID: 12554698 [Abstract] [Full Text] [Related]
13. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II. Maeda M, Shintani Y, Wheelock MJ, Johnson KR. J Biol Chem; 2006 Jan 06; 281(1):59-68. PubMed ID: 16267045 [Abstract] [Full Text] [Related]
14. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase. Wang D, Shen Q, Chen YQ, Wang MH. Oncogene; 2004 Mar 04; 23(9):1668-80. PubMed ID: 15001985 [Abstract] [Full Text] [Related]
15. Endofin acts as a Smad anchor for receptor activation in BMP signaling. Shi W, Chang C, Nie S, Xie S, Wan M, Cao X. J Cell Sci; 2007 Apr 01; 120(Pt 7):1216-24. PubMed ID: 17356069 [Abstract] [Full Text] [Related]
16. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II. Kalo E, Buganim Y, Shapira KE, Besserglick H, Goldfinger N, Weisz L, Stambolsky P, Henis YI, Rotter V. Mol Cell Biol; 2007 Dec 01; 27(23):8228-42. PubMed ID: 17875924 [Abstract] [Full Text] [Related]
17. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition. Peng SB, Yan L, Xia X, Watkins SA, Brooks HB, Beight D, Herron DK, Jones ML, Lampe JW, McMillen WT, Mort N, Sawyer JS, Yingling JM. Biochemistry; 2005 Feb 22; 44(7):2293-304. PubMed ID: 15709742 [Abstract] [Full Text] [Related]
18. ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN. Sflomos G, Kostaras E, Panopoulou E, Pappas N, Kyrkou A, Politou AS, Fotsis T, Murphy C. J Cell Sci; 2011 Oct 01; 124(Pt 19):3209-22. PubMed ID: 21878490 [Abstract] [Full Text] [Related]
19. SARA is dispensable for functional TGF-β signaling. Bakkebø M, Huse K, Hilden VI, Forfang L, Myklebust JH, Smeland EB, Oksvold MP. FEBS Lett; 2012 Sep 21; 586(19):3367-72. PubMed ID: 22819827 [Abstract] [Full Text] [Related]
20. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways. Dong F, Liu T, Jin H, Wang W. Can J Physiol Pharmacol; 2018 Jan 21; 96(1):1-7. PubMed ID: 28177668 [Abstract] [Full Text] [Related] Page: [Next] [New Search]